PCRX - Pacira Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PCRX is currently covered by 4 analysts with an average price target of $30.75. This is a potential upside of $10.16 (16.48%) from yesterday's end of day stock price of $26.4.

Pacira Pharmaceuticals's activity chart (see below) currently has 205 price targets and 155 ratings on display. The stock rating distribution of PCRX is 85.71% BUY and 14.29% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.48% with an average time for these price targets to be met of 281 days.

Highest price target for PCRX is $38, Lowest price target is $25, average price target is $30.75.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 01-Jul-2026. First documented stock forecast 18-Jan-2013.

Currently out of the existing stock ratings of PCRX, 6 are a BUY (85.71%), 1 are a HOLD (14.29%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-Feb-2020

$38

$12.12 (46.83%)

$38

29 days ago
(01-Jul-2026)

8/15 (53.33%)

$12.97 (51.82%)

518

Buy Since 30-Apr-2020

$32

$6.76 (26.78%)

$30

2 months 29 days ago
(01-May-2026)

11/32 (34.38%)

$7.56 (30.93%)

261

Hold Since 26-Mar-2026

$25

$-0.24 (-0.95%)

$18

4 months 4 days ago
(26-Mar-2026)

2/6 (33.33%)

$1.69 (7.25%)

50

Buy Since 07-Nov-2025

$28

$2.76 (10.94%)

$25

8 months 23 days ago
(07-Nov-2025)

1/6 (16.67%)

$5.95 (26.98%)

29

Sell Since 19-Feb-2025

$24

$-1.24 (-4.91%)

$21

1 years 2 months 14 days ago
(16-May-2025)

2/3 (66.67%)

$-1.86 (-7.19%)

185

Show more analysts

Please expand the browser size to see the chart

What is PCRX (Pacira Pharmaceuticals) average time for price targets to be met?

On average it took 281 days on average for the stock forecasts to be realized with a an average price target met ratio 59.48

Which analyst has the current highest performing score on PCRX (Pacira Pharmaceuticals) with a proven track record?

LIANA MOUSSATOS

Which analyst has the most public recommendations on PCRX (Pacira Pharmaceuticals)?

Liana Moussatos has 19 price targets and 15 ratings on PCRX

Which analyst is the currently most bullish on PCRX (Pacira Pharmaceuticals)?

Liana Moussatos with highest potential upside - $70.21

Which analyst is the currently most reserved on PCRX (Pacira Pharmaceuticals)?

David Amsellem with lowest potential downside - -$13.88

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?